These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7723401)

  • 1. Presentation of a PCR-nuclease protection strategy for minimal residual disease monitoring in B-ALL.
    Limón A; Bertran J; Llucià M; Carmona M; Canals C; Ortega JJ; García J; Rueda F
    Leukemia; 1995 Apr; 9(4):656-61. PubMed ID: 7723401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction.
    Inghirami G; Szabolcs MJ; Yee HT; Corradini P; Cesarman E; Knowles DM
    Lab Invest; 1993 Jun; 68(6):746-57. PubMed ID: 8515660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease.
    Steward CG; Potter MN; Oakhill A
    Leukemia; 1992 Nov; 6(11):1213-9. PubMed ID: 1434806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
    Potter MN; Steward CG; Maitland NJ; Oakhill A
    Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus JH gene probes with conjugated 3'-minor groove binder for monitoring minimal residual disease in acute lymphoblastic leukemia.
    Uchiyama M; Maesawa C; Yashima-Abo A; Tarusawa M; Endo M; Sugawara W; Chida S; Onodera S; Tsukushi Y; Ishida Y; Tsuchiya S; Masuda T
    J Mol Diagn; 2005 Feb; 7(1):121-6. PubMed ID: 15681483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of residual leukemic cells in acute lymphocytic leukemia of B-cells (B-ALL) by a nonradioactive PCR-based technique.
    Lendeckel U; Wex T; Frank K; Daoud A; Franke A; Ansorge S
    Cancer Detect Prev; 1996; 20(3):185-92. PubMed ID: 8769711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex PCR and Genescan analysis to detect immunoglobulin heavy chain gene rearrangement in feline B-cell neoplasms.
    Mochizuki H; Nakamura K; Sato H; Goto-Koshino Y; Sato M; Takahashi M; Fujino Y; Ohno K; Uchida K; Nakayama H; Tsujimoto H
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):38-45. PubMed ID: 21703693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
    Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
    Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
    Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
    Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
    Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
    Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease B cell lymphoma by a PCR-mediated RNase protection assay.
    Kurokawa T; Kinoshita T; Ito T; Saito H; Hotta T
    Leukemia; 1996 Jul; 10(7):1222-31. PubMed ID: 8684006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular diagnosis in hematopoietic malignancy].
    Hoshino A; Funato T; Sasaki T
    Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
    Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
    Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
    Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
    Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.